Security key
29405E406
Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB)
CUSIP: 29405E406
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 234,158
- Total 13F value
- $283,214
- Share change
- -19,051
- SEC-reported price per share
- $1.21
- Number of holders
- 14
- Value change
- -$34,110
- Number of buys
- 7
- Number of sells
- 8
- Shares outstanding
- 2,083,186
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
14
Top holders
10
ENVB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Enveric Biosciences, Inc. SEC filings
Enveric Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29405E406
Recent filing periods:
Ownership snapshot
Top reported holders of ENVB - Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Orca Capital AG
Disclosed value leader
AdvisorShares Investments...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 4.9%
13D/G row: Orca Capital AG
Showing 1-6 of 15 holder rows.
Quick read
Orca Capital AG leads the comparable SEC ownership view at 4.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Orca Capital AG's linked filing trail.
Comparable ownership
Top 5
Orca Capital AG
4.9%
AdvisorShares Investments LLC
4.3%
UBS Group AG
2.1%
HRT FINANCIAL LP
2%
GEODE CAPITAL MANAGEMENT, LLC
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Orca Capital AG |
13D/G
|
4.9%
|
$32,016
97,019 shares
|
-$22,984 | 31 Jan 2025 |
| AdvisorShares Investments LLC |
13F
Company
|
4.3%
|
$118,324
90,324 shares
|
— | 31 Mar 2025 |
| UBS Group AG |
13F
Company
|
2.1%
|
$59,436
42,760 shares
|
— | 31 Mar 2025 |
| HRT FINANCIAL LP |
13F
Company
|
2%
|
$56,000
40,625 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.3%
|
$36,915
26,558 shares
|
— | 31 Mar 2025 |
| Virtu Financial LLC |
13F
Company
|
1.2%
|
$36,000
25,622 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
234,158
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
14
Q2 2025 holders
14
Holder diff
0
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend